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Here we report a novel strategy for engineering liver sinusoids with de-
signed fenestrae that yield near uniform microfluidic flow conditions along
the length of the microstructure – capabilities enabled by the use two-
photon direct laser writing (DLW). To better model organ systems, re-
searchers have increasingly investigated the use of DLW as a promising
means for mimicking both architectures and length scales of physiologi-
cal components. DLW-based approaches could enable liver sinusoids to be
recreated in vitro; however, recent efforts to construct permeated tubules
exhibit dramatic decreases in fluid flow through the pores downstream. To
overcome such issues, here we applied microfluidic circuit theory and in-situ
DLW (isDLW) to manufacture liver sinusoids that included fenestrae with
distinct sizes to better maintain a consistent fenestra-specific flow profile.
Specifically, fenestrae radii were increased from 0.75 µm to 2.01 µm over
the length of a 510-µm sinusoid. Theoretical results revealed that the flow
rate through the fenestrae could be more maintained along the length of the
optimized sinusoid versus the unoptimized sinusoid with uniform fenestrae
which results in inconsistent fluid flow. Preliminary results revealed suc-
cessful isDLW fabrication of the optimized sinusoid, with proof-of-concept
microfluidic flow demonstrations that suggest that the presented strategy
could benefit numerous biomedical applications. These results suggest the
potential of this design strategy for liver on-a-chip modeling, and given the
numerous anatomical structures similar to the presented fenestrated sinu-
soid, this approach could be extended to model additional organ systems
of the body for disease modeling and drug screening.
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1 Introduction
The Food and Drug Administration requires that candidate medications
meet several requirements before approval and dissemination to the market.
These candidate medications must prove to be both efficacious and nontoxic
at each of the main phases in the drug development process: in-vitro or
cell-based tests, in-vivo or animal models, and then finally multiple clinical
trials. On average it takes over two billion dollars and over a decade for
one drug to come out of this system [1]. This high cost is associated
with significant failure rates, many of which are due to problems with liver
toxicity [2].
The liver is primarily responsible for metabolism and filtration of the
bloodstream [3]. The metabolism of drugs in the body is done by the liver,
which is essential to consider in clinical drug testing. Novel drugs cannot
be approved if the drug and its metabolites are too toxic to liver cells
[2]. Therefore, we aim to develop an organ-on-a-chip liver sinusoid model
that can mimic microarchitectures in the liver and expedite this screening
process.
The model will be structured similarly to the liver sinusoid, which was
selected due to its role as the center of drug processing in the liver [4]. The
liver is made up of functional liver lobule subunits. Each lobule contains
sinusoids which are fenestrated microchannels that transport nutrient-rich
blood to the surrounding hepatocytes, the primary cells of the liver [5].
This arrangement allows hepatocytes to effectively metabolize drugs and
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nutrients in the bloodstream [5].
Traditional in-vitro models used in preliminary drug testing include
Petri dishes and multiwell plates. These conventional models lack certain
characteristics of physiological microenvironments [6]. These include static
fluidic conditions, inaccurate length scales, limitation to culturing a single
type of cell line, lack of mechanical stimuli, and flat “two-dimensional” ar-
chitecture [6]. The organ-on-a-chip field aims to address these issues. While
state-of-the-art models have addressed fluidic flow, more accurate length
scales, allowance for up to two cell type monolayers, mechanical stimuli,
these still have flat “two-dimensional” architecture [6]. Recent additive
manufacturing advancements that allow for the fabrication of structures
on the order of nanometers have the potential to advance the field through
the production of nanoscale models that capture even the smallest features
of organ physiology [7]. The goal of this project is to use microfluidics and
state of the art laser lithography technology to produce an organ-on-a-chip
model of the liver that will result in cellular behavior comparable to that
of a human liver.
The two central questions that motivate this research are:
1. Can an engineered microtubule with designed fenestrae yield
near-uniform microfluidic flow conditions along the length
of the microstructure?
2. How does the integration of this engineered microtubule
influence liver cell function?
We hypothesize that by using fluid modeling and direct laser writing
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(DLW) nano3D printing techniques, we can determine fenestrae of varied
sizes at specific points along the microstructure that optimize uniform fluid
flow through the tubules and fenestrae. Additionally, we hypothesize that
by mimicking the microarchitecture of a liver sinusoid and therefore mim-
icking the specific microenvironment of the liver sinusoid, liver cell function





2.1.1 Current Problems in Drug Development
As researchers synthesize potential drugs to improve the current meth-
ods of treatments for various diseases, the FDA must determine the degree
of human toxicity before the drug is released on the market. In-vitro tox-
icity testing is the scientific analysis of toxic substances on mammalian
cell lines. This preliminary testing is primarily used to identify hazardous
properties of potentially useful new pharmaceuticals [8]. The main goal of
in-vitro drug toxicity testing is to model the complex sequence of physiolog-
ical events in which interactions between cells and drugs, drug metabolites,
and drug protein conjugates may potentially lead to tissue damage. How-
ever, the level of molecular detail in metabolic processing is rarely captured
in current in-vitro cell culture models: new chemical compounds often fail
during late-stage human drug testing and can receive “black box” warn-
ings, which indicate that there are life threatening risks associated with the
medication and it is therefore not U.S. FDA approved [9]. One example of
these warnings is drug induced liver injury (DILI), which is a major reason
for drug failures in the drug development process [10]. DILI remains the
most common cause of acute liver failure in the U.S., accounting for 13%
of all acute liver failure cases in 2005 [11]. In-vitro cell-based assays and
preclinical in-vivo studies in animal models are often not adequately able
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to forecast potential issues like DILI, which has contributed to the costly
and inefficient drug development process.
2.1.2 Importance of Liver in Drug Development
The liver, depicted in Figure 1, is composed of a variety of structures
that work together to filter the blood from the digestive tract before cir-
culating it to the rest of the body. The detoxification of chemicals and
the metabolism of drugs are two functions of the liver that are critical in
the maintenance of homeostasis in the body [3]. The liver consists of cells
called hepatocytes, which house these detoxification and filtration processes
[12]. Hepatocytes are often grown in petri dishes to test drug toxicology
and measure the effects of other cell toxins. However, this method is not
entirely accurate because there are other structures within the liver, in-
cluding the sinusoids, hepatic artery, and portal vein that interact with
hepatocytes to contribute to liver function. The hepatic artery carries
oxygen-rich blood to the liver, while the portal vein delivers nutrient-rich
blood from the gastrointestinal tract. In order to achieve proper detoxifica-
tion of chemicals and metabolism of drugs, the hepatocytes in the liver rely
on the flow of blood from these major hepatic blood vessels. The vessels
carry the chemicals into the liver, where the hepatocytes then release the
enzymes necessary for metabolism [5].
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Figure 1: A diagram of a liver lobule highlighting the portal triad and
direction of blood flow from the portal vein to the central vein. The
sinusoids, represented by thin blue channels, are shown surrounded by
hepatocytes organized into plates, or cords [13].
2.1.3 Liver Bioarchitecture
Another important structure is the liver sinusoid. Sinusoids within the
liver contain a fenestrated, or porous, internal lining of endothelial cells
that allows for the filtering of fluids, particles and solutes between the
blood and surrounding hepatocytes. The sinusoids and major vessels of the
liver significantly contribute to liver function, which is why such structures
have been the main focus of past and current toxicology research efforts
for this organ [5]. Current in-vitro drug screening methods are unable to
accurately predict which compounds are likely to induce drug-related liver
injuries due to their inability to promote cellular functions that are critical
for drug metabolism [11]. This incongruence can be addressed through the
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maintenance of accurate tissue architecture in models for toxicity testing
as recapitulating the cellular microenvironment promotes accurate in-vivo
interactions. Tissue architecture encompasses the interactions of adjacent
differentiated cells, extracellular matrix (ECM) components and adhesion
molecules, growth factors, Ca2+ and ATP concentrations, and local pH [11].
These factors originally determine cell differentiation and enable cell func-
tions such as communication and mobility. Mandin–Darby Canine Kidney
(MDCK) cells, thyroid cells, and mammary cells have shown to sponta-
neously form cysts and tubules in 3D cultures, a physiologically normal re-
sponse, but are not formed in 2D cultures (Fig. 2 )[14]. This demonstrates
how the 3D coordination and integration of cellular interactions dictate tis-
sue level functions in terms of assembly and maintenance of homeostasis.
Tissue architecture and 3D geometry of the cellular scaffold is necessary
for physiologically relevant cellular organization which traditional forms of
monocultures lack.
Figure 2: 5 µm sections of spontaneously formed 3D MDCK cultures
with a different stain on each biochemical surface[9].
2.2 Microfluidic Models
An organ on a chip is a microfluidic cell culture device that is designed
to model the behavior of an organ or organ system. These devices are
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typically fabricated using soft lithography or photolithography in a similar
way to computer microchips [6]. Traditionally, organ-on-a-chip technology
involves culturing cells in hollow microchannels and applying fluid flow to
simulate physiological conditions. Researchers may also apply mechanical
forces, introduce structural components such as ECM, or include multiple
cell lines or tissue interfaces in an organ on a chip to mimic an organ’s
microenvironment [6]. For example, a lung-on-a-chip device created by re-
searchers at Harvard modeled the alveolar-capillary interface of the lung
and included vacuum chambers to simulate the mechanical effects of breath-
ing (Fig. 3). This successful model showed that it was feasible to develop
and use organ-on-a-chip systems for in vitro study [15]. After the original
lung on a chip, various models of other organs were created. One example
is the heart on a chip, which was found to better mimic the heart’s con-
tractions, yielding advancements in research involving the cardiotoxicity of
drugs [16].
Organ-on-a-chip technology is a complementary technology to other
3D cell culture types such as organoids and spheroids that have greatly
propelled research in understanding the effects of drugs on certain organs
[6]. One important note is that organ-on-a-chip devices do not seek to
grow an entire organ, rather, they model the smallest practical unit of an
organ to accurately replicate the functions of a system [6]. A developing
area of research using organ-on-a-chip technology includes the connection
of multiple organ-on-a-chip devices to model organ systems, such as the
excretory and renal systems. As this technology advances, researchers hope
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to create a human on a chip that incorporates all major organ systems
[17, 18]. Organ on a chips have great potential to replicate organ functions
of disease. As an example, the lung-on-a-chip device developed was used to
investigate pulmonary edema [19]. As time has progressed, organ-on-a-chip
devices have only advanced and continue to demonstrate great potential in
drug development [19].
Figure 3: Lung on a chip device with two vacuum chambers on each
side. This device recapitulates the alveolar-capillary interface by applying
mechanical stresses that mimic the effects of breathing [19].
2.2.1 Liver on a Chip
Compared to traditional 2D models, organ-on-a-chip devices have sev-
eral important benefits. One advantage is that these devices provide the
ability to manipulate the 3D cellular environment [20]. In addition, these
devices expose cultured cells to mechanical forces found in the human body,
such as fluid flow, tension, and compression, which influence cellular devel-
opment and interaction [6, 21]. This is in marked contrast to traditional 2D
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cultures and even 3D cultures that lack fluid flow [14]. As previously stated,
the liver is an important system of interest for organ-on-a-chip modeling
due to its role in toxin filtration and drug metabolism [3]. In the past, stud-
ies have indicated that liver-on-a-chip devices exhibit greater liver-specific
enzymatic activities and responses to chemical stimuli compared to two-
dimensional petri dish models [22]. Ultimately, these liver-on-a-chip models
share the goal of understanding how liver cells in biologically complex 3D
arrangements communicate with one another and with their surroundings,
with the ultimate goal of imitating liver function [22]. The use of these
structures is an important step in understanding how the human liver re-
sponds to drugs and other chemicals, which may lead to the development
of an improved in-vitro platform for clinical drug testing.
A variety of liver-on-a-chip models have been created using traditional
and contemporary 3D fabrication methods. Organ-on-a-chip devices are
typically created using soft lithography, enabling complex patterns to be
integrated into biologically compatible materials [23]. For example, soft
lithography was used to fabricate a device containing a radial pattern of
pillar arrays with HepG2 cells in a collagen hydrogel (Fig. 4). This device,
which was designed to structurally mimic the hepatic cord-like system of the
liver, allowed researchers to quantify metabolic cellular responses to known
drug-drug interactions. In addition, it was determined that this model
expressed higher levels of enzyme activity than liver cells in 3D culture,
indicating that it may be valuable in the clinical drug testing process due
to its heightened metabolic activity [22].
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Figure 4: Development of a liver-on-a-chip model that mimics the
hepatic cords of the liver. The structure of hepatic cords arranged around
the central vein presented in (a) and in more detail in (b) is captured in
the microfluidic device in (c). The pillar arrays containing HepG2 cells
are displayed in detail in (d) [22].
To accurately replicate the 3D microenvironment of the liver, there are
a few basic techniques that most researchers take advantage of in their
models. One of the most important is the flow of media, which exposes the
cells to shear stresses that are commonly encountered in the body through
functions such as breathing and muscle contractions [6]. Most microfluidic
devices also use some form of cell patterning, which allows researchers to
deposit certain types of cells in specific locations on the device to mimic
cellular arrangement in a given organ [6]. This can be achieved through
direct cell printing or the incorporation of microchannels, which are also
11
frequently used to evaluate cell and nutrient transport and facilitate fluid
flow. Another important element of the device is the type of cells that are
cultured in or on it. One common cell line used to study the liver is a series
of biologically immortal Hep G2 cells. Hep G2 cells are also commonly used
in studying cytotoxic and genotoxic compounds in the liver and have been
studied in liver-on-a-chip devices [22, 24]. Another cell line is the human
hepatoma cell line, HepaRG, which retains the expression of many liver-
specific functions and enzymes but is still much less expressive than primary
hepatocytes, which are the gold standard of in-vitro testing [25].
2.2.2 Previous Experimental Applications of Liver-on-a-Chip Tech-
nology
Liver-on-a-chip technologies have been used for many applications, such
as emulating cell signalling pathways, creating accurate disease models, and
containing the spheroids and flow of media (Fig. 5). Metabolic activity and
albumin production was discovered to be greater in the co-culture model in
comparison to a control that was not exposed to paracrine signaling, sig-
nifying that cell-cell interactions may positively affect biological relevance
in a liver model [26].
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Figure 5: Paracrine signaling in the liver. (a) Design schematic of a
concave chamber containing Hep G2 spheroids and a flat chamber
containing HSCs. The two chambers were connected to allow media from
the HSC chamber to flow to the Hep G2 chamber. (b) Experimental
setup containing chambers connected by tubing, a media source, and a
connection to an osmotic pump [26].
Liver-on-a-chip devices have also been significant in the research of dis-
eases and syndromes. One implementation of this technology was the cre-
ation of an in vitro model of an alcohol diseased liver. Liver damage was
simulated by exposing spheroids of rat-derived hepatocytes and hepatic
stellate cells to differing concentrations of ethanol, then inserting them into
the microfluidic device. The chip accurately simulated the diseased liver
on the basis of albumin and urea secretion in the models with 60 - 80µL
exposure to ethanol, and also displayed the onset of fibrosis [27]. This work
provides experimental evidence that secretion of albumin and urea may be
important indicators of metabolic function in the liver [27]. Liver-on-a-chip
models are also being used to research drug interactions inside the body.
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One use of liver-on-a-chip technology allowed for drug screening through
the analysis of hepatocyte metabolism. A microfluidic device was created
to analyze acetaminophen metabolites in relation to hepatic cell cytotoxic-
ity, showing the inverse relationship between acetaminophen concentration
and metabolite production [28].
Although some processes mainly require only the function of one organ,
other processes do not occur in isolation and thus require the interaction
of multiple systems. In one study, nephrotoxic effects of ifosfamide, an
anticancer drug, were only observed when a liver-on-a-chip and a kidney-
on-a-chip system were connected [29]. Soft lithography was used to create
a liver and skin cell co-culture system in a microfluidic organ-on-a-chip
device. The co-cultures operated at a steady metabolic rate and the skin
cells took up the albumin produced by the hepatocytes [30]. In an extension
of this study, intestine, skin, kidney, and liver equivalents were all cultured
in a similar microfluidic device. Absorption, distribution, metabolism and
excretion profiles were created for the 28 days during which there was
homeostasis between the four types of cells, providing data for improved
toxicity testing [31].
Yet another microfluidic device was created through soft lithography
which compartmentalized four various types of cells: liver, lung, kidney,
and adipose cells. The device allowed for fluidic interactions between the
cells while limiting crosstalk between the organs, thus allowing supplements
like growth factors to only interact with one cell type while not affecting the
other cells [32]. This enabled more accurate toxicity modeling of multiple
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co-cultures in a microfluidic device, as a single biochemical like TGF-β1
can be delivered in isolation to enhance the function of a specific cell type
like the lung cell line in this example without changing the functions of the
other co-cultured cell lines [32]. This illustrates the importance of organ-
organ interactions, as the drug was activated in the liver for nephrotoxic
effects.
2.3 Additive Manufacturing
In addition to soft lithography, additive manufacturing provides a num-
ber of advantages in the development of liver-on-a-chip models. Different
types of 3D printers can rapidly fabricate precise structures on the res-
olution of microns, directly print cells in complex 3D arrangements, and
conveniently utilize a variety of materials. By taking advantage of addi-
tive manufacturing technology, researchers have been able to emulate the
complex microenvironment of human organs with increasing precision. Ad-
ditive manufacturing (3D printing) produces 3D objects through layering
of material aided by a computer program (Fig. 6). This innovative method
of printing has been applied to fields such as engineering, manufacturing,
art, education, and medicine [33]. Different methods of 3D printing can be
utilized depending on desired function and properties of the product.
15
Figure 6: Multiple methods of 3D printing. (a) Traditional petri dish
model with a 2D cell monolayer. (b) Single-layer microfluidic system with
a 2D cell monolayer and introduction of fluid flow to the model. (c)
Multilayer microfluidic system with a 2D cell monolayer on an intervening
porous membrane, allowing for more than one cell line to be cultured in
one model. (d) Tubular porous membrane with a 3D cell monolayer. (e)
Stereolithography (SLA). Focused light induces localized
photopolymerization (white) of a photocurable material (blue) to
fabricate 3D structures. (f) PolyJet Printing (PJP)/MultiJet Modeling
(MJM). Multiple inkjets in parallel deposit microdroplets of photocurable
material and sacrificial support material simultaneously to fabricate 3D
structures. (g) Extrusion-based printing. Material is extruded through a
nozzle and deposited to fabricate 3D structures [34].
2.3.1 Additive Manufacturing Methods
Extrusion-based printing involves the deposition of material in a point-
by-point manner through a nozzle [35]. This method has been used to
bioprint cell-laden hydrogel 3D structures with built-in microchannels to
ultimately produce large-scale organ models [34]. Extrusion-based printing
can also involve printing sacrificial material, material that will be removed,
or cell compatible material to create 3D microsystems. One basic fabri-
cation procedure for biological constructs involves 3D printing a sacrificial
material, applying a liquid cell-compatible material surrounding or inside
the sacrificial material, curing the cell-compatible material, and removing
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the sacrificial material to leave only the cell-compatible material behind.
This type of fabrication is limited in time consumption and geometrical
complexity [35, 36]. Polyjet printing dispenses microdroplets of photocur-
able resins, known as photopolymers, and cures them in thin layers to
create a 3D object. This type of printing often requires a sacrificial sup-
port material, which can be removed to leave only the photopolymer [35].
A physiologically accurate descending aortic model was created using poly-
jet printing due to this method’s geometrical accuracy, speed, and low cost
of production [37]. In a 2016 study, 3D printing techniques were investi-
gated by comparing microfluidic fabrication parameters. Polyjet printing
was shown to be superior to other forms of 3D printing based on spatial
accuracy, surface roughness measurements, and printing resolutions [27].
Stereolithography is a 3D printing method that incorporates direct laser
writing to create microfluidic channels and complex geometric structures
[35]. The method involves using focused light to photocure liquid polymers
layer by layer, leading to the creation of a 3D structure [38]. This form of
3D printing aided in the study of how 3D microenvironments affect can-
cer cell growth and movement. Photocurable polyethylene glycol diacrylate
was used to create log-pile microarchitectures, allowing for the construction
of precise structures through stereolithography. Results showed that both
types of cells tested displayed different migration properties in 3D scaf-
folds compared to 2D scaffolds, demonstrating a difference in physiological
accuracy between 3D and 2D models [39].
Laser lithography was used as a stereolithography technique for its abil-
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ity to create high resolution structures with dimensions as small as 100
nm through precise photopolymerization by a laser [40]. Because of the
precision of laser lithography and the elasticity of the printing material
OrmoComp, a biocompatible gel with high chemical and thermal stability,
researchers determined forces exerted by primary cardiomyocytes were only
observed using complex structures resembling in vivo extracellular matri-
ces. However, a limitation of the laser lithography technique is the height
constraint of the microscope lenses, which in one study was 80 µm, limiting
the size of channels and possibly interfering with physiological length scales
[40].
2.3.2 Nanoscribe
The 3D printing machine that will aid in achieving the proposed 3D
liver model is the Nanoscribe Photonic Professional GT printer, due to its
combination of high resolution (Fig. 7) and the moving beam capabilities
of the printer [41]. This machine is optimal for mimicking organ structures
because it is able to print in a 200 µm circular area without sacrificing
accuracy without the need for a moving base [42]. This capability is derived
from the moving beam fixed sample functionality of the printer, allowing
structures to be printed on the resolution of micrometers [41]. Because
the liver has microarchitectures that directly affect its function, such as its
sinusoid channels, the ability for the Nanoscribe to create small biophysical
structures makes it an optimal tool for this project [43].
The type of stereolithography the Nanoscribe uses is two photon laser
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writing of various UV-curable photoresist materials [41]. Two photon laser
writing is caused by ultrashort laser pulses which initiate polymerization
of photosensitive material through two photon absorption. After removal
of unpolymerized resin, the desired 3D structure remains [44].
There are a variety of biocompatible materials that can be used by the
Nanoscribe to print these structures. An alternative to these materials
is photopolymerizable biocompatible photoresist that forms a patterned
coating on the surface. OrmoComp, a photoresist, was found to support
cell growth and rapidly solidify after exposure to 40 minutes of UV radiation
[45]. This is a promising biocompatible material with the ability to produce
a durable structure, especially for a 3D organ model. Additionally, the
machine can also utilize specifically designed negative IP-photoresists that
increase the 3D microfabrication capabilities. Negative photoresists keep
the areas exposed to the laser while the areas not exposed to the laser
can be dissolved. The negative IP-photoresists provided by the Nanoscribe
company are able to form 150 nm structures, increase print speed, increase
mechanical stability, and decrease mechanical stress during printing [41].
Figure 7: The Photonic Professional GT Nanoscribe printer
demonstrates a variety of printing resolutions, varying from the nanoscale
(1 µm) to the macroscale (200 µm) [41].
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The Nanoscribe is able to print within the channels of devices made from
a variety of materials. One such material, polydimethylsiloxane (PDMS)
is a common silicon in soft lithography techniques; however, although it
is cost efficient and easily fabricated, its hydrophobicity causes it to be
unstable [46]. Another commonly used biomaterial for scaffolding is fibrin
hydrogel, prepared from fibrinogen and thrombin. In one study, the hy-
drogel provided a medium on which cells could adhere and multiply, but it




This project aimed to fabricate a novel liver-on-a-chip device on a physi-
ologically relevant scale that mimicked in-vivo hepatic activity. This device
is composed of a cell containment chamber to house cultured hepatocytes,
as well as input and output pores for fluid flow (Fig. 8a). In addition,
the device included a porous microchannel through the cell chamber repre-
senting a liver sinusoid with the ability to diffuse nutrients to surrounding
cells (Fig. 8b). This design allows for constant fluid flow throughout the
liver model, creating a dynamic environment unlike the static conditions
present in conventional organ models. The 3D bioarchitectures of this
liver-on-a-chip device also reduce the physiological inaccuracies present in
conventional organ models, allowing hepatic activity to be better modeled.
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Figure 8: (a) CAD rendering of the liver-on-a-chip device design
showing input and output holes for fluid flow (orange). (b) CAD
rendering of cell containment chamber showing cell media input (blue),
output (red), and fluid dispersion into the chamber (green).
In order to achieve this, a strategy for engineering liver sinusoids with
designed fenestrae was developed using conventional microfluidic circuit
theory and in-situ two photon direct laser writing (isDLW). This hybrid ap-
proach allowed for physiologically accurate fabrication of the device bioar-
chitectures. First, a traditional microfluidic device was designed to house
the nano-3D printed bioarchitectures. Then, isDLW was used to nanofab-
ricate a porous microchannel within the microfluidic device to represent
a liver sinusoid. This microchannel was designed with inner and outer
22
diameters of 35 µm and 45 µm, respectively. Sets of fenestrae were also
designed along the length of the microchannel with initial pore size of 0.75
µm to serve as pores allowing for the diffusion of necessary nutrients, but
not cells. This design, however, showed limitations as fluid pressure de-
creased along the length of the microchannel, resulting in reduced fluid
diffusion through the microchannel fenestrae. To create uniform flow diffu-
sion along the length of the microchannel, fenestrae pore size was adjusted
along the length of the fenestrae using circuit theory and finite element
analysis (FEA) (Refer to Section 3.2).
3.2 Theoretical Methodology
One defining component of this device is its ability to sustain consistent
volumetric output flow rates through the fenestrae along the entire length of
the 3D printed construct. This element of the design is necessary to ensure
that surrounding cells receive equal amounts of media, and therefore an
equivalent nutrient supply, regardless of their location in the device. In an
unoptimized fluid flow model in which the pore size is constant along the
length of the construct, the output flow rate decreases linearly as fluid is
lost to the surroundings and the pressure of the fluid flowing through the
central tube decreases.
Circuit theory and finite element analysis (FEA) were utilized to design
and validate the optimized pore design prior to fabrication. Circuit theory
was applied to model fluid flow in the fenestrated tubule with the goal
of calculating the pore sizes required to produce equal output flow rates
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along the length of the construct. The equation that relates the voltage
to the current and resistance in an electric circuit, called Ohm’s Law, is
shown below. For pipe flow, voltage is analogous to the pressure difference
between the fluid inlet and outlet, current to the volumetric flow rate, and
















∆P = Pin − Pout (3)
The fenestrated tube was modeled as a circuit in which the intermediate
central tube segments and individual pores represent resistors. Placing
multiple pores at the same location along the central tube allows each set
of pores to be modeled as a group of resistors in parallel. The intermediate
resistances conferred by the central tube act in series with each other and
also with each set of pores. This model is depicted in Figure 9.
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Figure 9: (a) Circuit theory model of pipe flow through a fenestrated
tubule. (b) Representations of elements from circuit theory on a
fenestrated tubule.
Analysis of the flow equations was conducted to evaluate the resistance
of each set of pores required to maintain an equivalent output volumetric
flow rate along the whole construct. There were multiple assumptions
used in the creation of this model. The central tube diameter and the
spacing between pores is assumed to be constant, such that the intermediate
resistance RT is constant. The distance between pores (the length used in
the equation to determine the resistance RT ) is measured from the center
of one set of pores to the center of the next. It was also assumed that the
flow rate through the central tube must be greater than the sum of the
flow rates from the pores. In this model, the resistance of the first set of
pores (and therefore the radius of each pore in the first set) is treated as
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an independent variable.
The equation for the resistance Rn at each pore set as a function of the
pore row number (n) and maximum number of pore sets (nmax) was found
to have the following general form:







The general form equation is used to calculate the total resistance of
each pore set. Given the number of pores in each set, the equation for
equivalent resistance in parallel can be used to calculate the resistance of
each pore (Ri). Finally, using the Hagen-Poiseuille equation for resistance
as a function of pore length and radius, the radius of each individual pore
(r) can be calculated given that the wall thickness of the tube (the length











It was also discovered that in order to maintain distinct pores (prevent






As an example, for a system with 3 resistors (Fig. 10), the follow-
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ing fundamental equations were outlined according to the basic pipe flow
equations.
Figure 10: Circuit theory model of pipe flow through a fenestrated
tubule containing three sets of pores.
Pin − P1 = RT ·QA (8)
P1 − P0 = R1 ·QP (9)
P1 − P2 = RT ·QB (10)
P2 − P0 = R2 ·QP (11)
P2 − P3 = RT ·QC (12)
P3 − P0 = R3 ·QP (13)
P3 − P0 = RT ·QD (14)
QA = QB +QP (15)
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QB = QC +QP (16)
QC = QD +QP (17)












P2 − P0 = QC ·RC (21)






which was substituted into equation 13 for QC :




By substituting the right-hand side of equation 4 for the right-hand side of
equation 17 and simplifying, the following expression was obtained for R2:




Further substitution with equation 11 for RC and simplification resulted in






In a similar manner and by substituting in the previous equation for R3,





The equation for R2 agrees with the derived equation for the general form.
Using these equations, a MATLAB program was created such that the
user can specify the following values (input) and obtain an output vector
containing the radius of each pore, with the index in the vector correspond-
ing to the pore row number n. These values were used to design the pore
sizes in the optimized construct. The program also returns the flow rate
through the first intermediate segment, Q(1), which is used as the input
flow rate later on in finite element analysis (FEA) to validate the design.
Inputs
Desired volumetric flow rate through each set of pores
Intermediate tube length (length between pore centers)
Center tube inner radius
Center tube wall thickness
Radius of each pore in the first set
Number of pores per set
Number of pore sets
Table 1: Custom MATLAB program inputs used for design of an
optimized microfluidic tubule.
Outputs
Radii of individual pores in each of nmax pore sets
Flow rate through first central tube segment
Table 2: Custom MATLAB program outputs used for design of an
optimized microfluidic tubule.
To determine the effectiveness of the mathematical model, output vol-
29
umetric flow rates in a tube with modified pore sizes as described above
(optimized) and a tube with uniform pore sizes (unoptimized) were com-
pared using finite element analysis (FEA). All simulations were performed
using COMSOL Multiphysics v5.3a (COMSOL Inc., Sweden). 3D CAD
models of each tube were created in SolidWorks according to the calcu-
lated dimensions and imported into COMSOL. Briefly, each pore surface
was selected as an open boundary, while the appropriate ends of the cen-
tral tube were selected as an inlet and outlet, respectively. Hydrodynamics
equations corresponding to creeping flow were solved using these condi-
tions, with all other boundaries set to no-slip conditions. The flow rate of
the one dimensional flow field directed normally to the inlet surface was set
to a velocity (m/s) corresponding to Q(1), which is the calculated flow rate
through the first intermediate section of the tube prior to any encounters
with the pores. Water at 37 °C was selected as the input fluid for all sim-
ulations, and a normal mesh was created. A stationary study for steady
state flow was then conducted, and the volumetric flow rate at each open
boundary was recorded after running the simulation.
3.3 Fabrication Methodology
Our devices were fabricated using a combination of standard soft lithog-
raphy and direct laser writing techniques (Fig. 11). First, a negative mold
was printed and molded with polydimethylsiloxane (PDMS). PDMS was
used as it is an inexpensive polymer with rubbery mechanical properties.
Furthermore, the gas permeability of PDMS allows for the culture of live
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cells without additional gas exchange mechanisms [48]. This micromolded
PDMS was then hole punched and bonded to a glass substrate. Hollow
microarchitectures with fenestrations were printed in the channels in order
to house cells and distribute media or fluid in a physiologically relevant
environment.
Figure 11: Device fabrication process. (a) Direct laser writing of the
mold on a silicon wafer. (b) Printed mold on a silicon wafer. (c)
Polydimethylsiloxane (PDMS) cured on the mold. (d) PDMS taken off
the mold and bonded to a glass slide.
3.4 Microfluidic Device Manufacturing
3.4.1 Negative Mold Manufacturing
The 3D CAD model of the mold was created using through the computer-
aided design software SolidWorks (Dassault Systemes, France). A nega-
tive mold was printed with a Nanoscribe Professional Photonic GT (Nano-
scribe) printer on a silicon wafer. The mold was designed such that input
and output ports could be created for fluid and cell flow. The mold was
structured with two input and two output channels structured with tri-
angular cross sections 50 µm in height to prevent deformation observed
during iterations of the fabrication process (Fig. 11a-11b). One input and
one output channel in line with each other are fabricated for the purpose of
inputting and outputting the majority of fluid flow. The other input and
output channels allow for cell inputs around the printed isDLW fabricated
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channel. At the intersection of the four channels there is a box 100 µm
tall and 250 µm by 250 µm wide, for the purpose of allowing observation
of cell interactions surrounding the isDLW fabricated channel. The silicon
wafers were cleaned with a wash of acetone and isopropyl alcohol (IPA),
and then dried with inert nitrogen gas. The Nanoscribe was used with
a 25x objective lens in DiLL mode to print the molds comprised of the
negative-tone photoresist, IP-S (Nanoscribe), onto the silicon wafer print
substrates. The channel molds were fabricated with layer heights of 1 µm
and hatching distances of 1 µm. For DLW, the laser power and scan speed
were set to 50 mW and 100 mm/s, respectively. The writing time for the
negative molds was 20 minutes.
Following the DLW process, substrates were developed first in a bath
of propylene glycol monomethyl ether acetate (PGMEA) for 20 minutes
to remove any uncured photoresist, and then in IPA for 5 minutes so the
remaining liquid could next be evaporated at 70 °C for 5 minutes resulting
in the desired, ready to use, negative mold.
3.4.2 Micromolding
A 10:1 ratio of elastomer base to curing agent was mixed to prepare the
PDMS (Sylgard, Corning, New York). After using a dessicator to remove
the excess air bubbles in the mixture, the PDMS was poured over the
mold. The wafer with PDMS was put into the desiccator again to remove
any additional air bubbles, and then cured overnight at room temperature
or for 3 hours at 60 °C on the hotplate. The structure was further refined
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to remove excess PDMS, leaving a square shaped device. Holes with a
diameter of 0.75 mm were created in the device at the ends of the imprinted
cross pattern to create input and output valves that would interface with
the microchannels.
3.4.3 Glass Bonding
In order to seal the channels, the devices were bonded to a circular glass
slide with diameter of 30 mm. The devices were cleaned with Isopropyl
alcohol (IPA) and dried with inert nitrogen gas prior to bonding. The
glass slides were cleaned with acetone, followed by IPA, dried with inert
nitrogen gas, then placed on a 120 °C hot plate to dry off completely.
The device and glass were placed in the Branson Barrel Resist Stripper
(Branson/IPC, New York) with the pattern on the device facing up. The
power of the machine was set to 150 W with the oxygen plasma on for
45 seconds. The device and glass were then removed and the device was
pressed onto the glass with the patterned side facing the glass. The bonded
device was placed on a 120 °C hot plate for 10-20 minutes to ensure a tight
seal.
3.4.4 Sol-Gel Coating
To minimize substrate adsorbtion by the PDMS device, sol gel was run
through the microfluidic device channels to coat the channels with a layer
of APTES. (Fig. 12) [7]. A solution of 33% APTES in EtOH was run into
the device channels for 5 minutes to allow the APTES to diffuse onto the
surface of the device channels. This solution was cleared with air pressure
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and a 33% acetic acid (AcOH) catalyst was perfused into the channel for 3
minutes. The device was then placed on a hot plate at 90 °C for 4 minutes
to evaporate the solution. This process was included in the processing of
these devices as it has been shown to minimize detachment of internal 3D
printed structures [7].
Figure 12: Sol-gel coating of PDMS with 3-aminopropyltriethoxysilane
(APTES) [7].
3.4.5 Vacuum Loading of Photoresist
The sol-gel coated PDMS on glass devices were then vacuum loaded
with a negative-tone photoresist to prepare for printing of the tubules.
Tape was placed over two of the ports to create a seal, and the device was
placed under a vacuum for 10 minutes. Photoresist was applied on top of
the two open ports and allowed to flow into the channels for 5 minutes.
The tape was then removed.
3.4.6 Microarchitecture Fabrication
The Nanoscribe PPGT was used again to print hollow microchannels
with defined inner and outer diameters and containing patterned pores and
in order to replicate the fenestrated endothelium architecture. Through the
use of piezo-actuators that allow for ultra-fine guiding of the laser, micro-
architectures can be precisely photocured from the material of choice.
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In addition, the DeScribe (Nanoscribe, Stutensee, Germany) software
associated with the Nanoscribe is compatible with .stl files generated from
SolidWorks allowing for CAD designs to undergo post-processing to be
suitable the NanoWrite software that directs the Nanoscribe. The mi-
croarchitectures developed for three seperate devices used the Nanoscribe
PPGT to print various hollow microchannels. One device featured a solid
tube microarchitecture, while another featured evenly sized pores in the
microchannel and the last featured a computationally determined set of
variable pore size in the microarchitecture to have even fluid distribution
throughout the device. The channel lengths all equaled 510 µm, with ad-
ditional triangular walls 20 µm thick to create a sealed fluidic connection
from the triangular channels to the central square environment.
The Nanoscribe was used to fabricate the microchannels with a 63x
objective lens in DiLL mode to print the molds comprised of the negative-
tone photoresist, IP-L 780 (Nanoscribe, Stutensee, Germany), onto 107
µm thick glass print substrates. The microchannels were fabricated with
layer heights of 0.3 µm and hatching distances of 0.3 µm. For DLW, the
laser power and scan speed were set to 22.5 mW and 10 mm/s, respec-
tively. The writing time for the microchannels was 12 minutes. Following
the DLW process, substrates were developed first in a bath of propylene
glycol monomethyl ether acetate (PGMEA) for 24 hours to remove any
uncured photoresist. Devices were then placed for 5 minutes on heat so the
remaining liquid could be evaporated at 100 °C.
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3.4.7 Scanning Electron Microscopy
Scanning electron microscopy (SEM) images of samples were taken with
Field Emission Gun Scanning Electron Microscopy (FEGSEM) operating
at 10.0 kV. Samples were first mounted on an aluminum stub and then
carbon sputtered (Balzers MED 010 Carbon Coater) with a thickness of
roughly 10 nm before analysis with SEM (Tescan XEIA3 FIB/SEM).
3.5 Fluid Flow Testing
3.5.1 Flow Visualization in 3D Printed Tubules
In order to control fluid flow, a pressure control system was used. This
system utilized a pressure regulator device to control the pressure applied to
a fluid. The device system that was used was designed specifically for organ-
on-a-chip systems, as it includes the capacity control to critical parameters
such as flow induced shear stress, mechanical simulation, and air-liquid
interface [49]. The specific system that was used is the Fluigent MFCS™-
EZ system, shown in Figure 13. The MFCS-EZ has 4 channels that can
be controlled on the computer using MAESFLO software, also shown in
Figure 13. This software can regulate the pressure of the fluid flowing
through each channel [50]. In addition, Fluigent flow sensors were used
in conjunction with the MFCS-EZ system as a means of measuring the
speed of the fluid flow [51]. Autofluorescent polymer-based particles with
a diameter of 300 nm (Thermo Scientific, Massachusetts) were dissolved in
a 1:1000 dilution by volume in water. This solution was pumped through
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the channels to observe the fluid flow out of the pores of the microtubule
in the device using the Axiocam 503 Mono Microscope (Zeiss, Germany)
at 18 mbar [7].
Figure 13: Fluigent MFCS-EZ system and Maesflo software used for
fluid flow testing [50].
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3.5.2 Leakage Test
A leakage test was conducted to determine if there was an intact seal
between the 3D printed structures and the walls of the microchannel. A
microfluidic device was formed using an H-shaped negative mold. Next, a
semicircle-shaped barrier was printed using the Nanoscribe in the central
portion between the two parallel channels of the device. Using the Fluigent
system, pressurized water was inputted through one of the channels at
incrementally increasing pressure until the fluid burst through the printed




The fenestrated tubule design was created using the derived equation
for resistance as a function of pore row number (general form), the derived
inequality governing restrictions on pore size, the Hagen-Poiseuille equation
for resistance, and the equation for resistance in parallel that is governed
by hydraulic circuit theory.
For theoretical studies, tubules with the following dimensions were fab-
ricated in SolidWorks.
Parameter Value
Inner diameter 35 µm
Wall thickness 5 µm
Pore row number 50
Number of pores per set 5
Radius of first pore 0.75 µm
Spacing between centers of pore rows 10 µm
Table 3: User-specified parameters for design of an optimized
microfluidic tubule.
The value for the inner diameter was selected to reflect the diameter of
a large sinusoid without the presence of endothelial cells. This is because
our initial intention was to culture a thin layer of endothelial cells within
the 3D printed channels, therefore necessitating a larger tubule diameter.
While typical liver sinusoid diameters range in size from 7-15 µm, the
vascular endothelial cells that line the inner wall have diameters of around
6.5 µm [52]. Therefore, the expected diameter of a large sinusoid without
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the endothelial cells would be: 15+2(6.5)=28 µm. Our model includes
some extra space for replicability, with an inner diameter of 35 µm. A wall
thickness of 5 um was chosen because it is similar to the diameter of an
endothelial cell. This is significant because the sinusoid walls are themselves
composed of endothelial cells with a thin basement membrane. In addition,
this size could be reliably printed without collapsing. A tubule length of
510 µm was chosen because it represents the length of a sinusoid within a
typical liver lobule. Lobules are generally around 1 mm in diameter, with
sinusoids branching in from the exterior to the portal vein in the center
[53]. Therefore, the distance to the portal vein is around 500 µm.
The spacing between the centers of each pore row, and deductively the
number of pore rows, was chosen such that a nontrivial increase in pore size
could be observed without broaching the governing inequality of the model.
The number of pores per set was also chosen according to this reasoning.
For the non-optimized design, the radius of each pore was set to 0.75 µm.
For the optimized design, the radii of the pores in the first set only were
designated as 0.75 µm. The radii of the pores in each of the subsequent
sets were calculated using the custom MATLAB program. Figure 14 shows
the pore radii for each of the 50 pore rows in the optimized design.
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Figure 14: Pore radius as a function of pore row number in the
optimized tubule. Each row contains five individual pores.
The CAD designs of each of the tubules are shown in Figure 15.
Figure 15: (a) CAD rendering of the unoptimized tubule design with
consistent pore radii. (b) CAD rendering of the optimized tubule design
with variable pore radii.
The desired output volumetric flow rate through each set of pores was
selected such that the input volumetric flow rate Q(1) corresponded to
an input velocity of 0.5 mm/s, which is the approximate blood flow rate
through the sinusoids. The viscosity of water at 37 °C was chosen as a
representative for blood in the Newtonian model. The values of the input




Flow rate through each set of pores 7.78 · 10−16 m3/s
Fluid viscosity 6.922 · 10−4 Pa
Table 4: User-specified values of input parameters related to fluid flow.
Results displaying the output volumetric flow rates computed by COM-
SOL for the unoptimized and optimized designs are shown in Figure 16.
Figure 16: Fluid velocity magnitude plots generated in COMSOL for
(a) unoptimized and (b) optimized tubules. Output volumetric flow rate
relative to the first set of pores is represented by red arrows.
As seen in Figure 16a, the flow rate in an unoptimized design decreases
significantly relative to the first pore, with almost no flow at the 50th and
final set of pores. In the optimized design, flow appears to be steadily main-
tained until around the 42nd set of pores, where it decreases marginally. A
quantitative representation of these results is shown in Figure 16b.
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Figure 17: Percent decrease in volumetric output flow rate as a function
of pore row number in tubules with uniform and designed (modified)
fenestration.
The percent decrease in flow rate relative to the first pore, described
in Figure 17, increases linearly for the unoptimized design, with a nearly
100% decrease at the final set of pores. In contrast, the optimized design
produces a negligible change in flow rate in the first half of the tubule (up
to around pore number 25), followed by a marginal (4%) decrease by the
40th row and finally an ultimate decrease of around 18% by the final pore
row.
4.2 Device Fabrication
Fabrication of the microfluidic devices begins with the clear and viscous
PDMS elastomer and curing agent mixture, as described in Figure 18.
Figure 18a shows the initial materials which are generally clear and viscous
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with very few bubbles. These materials are thoroughly mixed to fully blend
in the curing agent, through which air is incorporated into the mixture. To
eliminate these air pockets, the mixture is placed in a desiccator, leaving the
mixture looking more opaque and frothy in texture. Desiccation continues
until the mixture is completely clear, and all bubbles are eliminated. This
clear mixture is then poured on to the inverse molds, as seen in Figure 18b,
and allowed to cure on gentle heat. Figure 18c shows the hardened PDMS
once cured and is no longer malleable to a shape. If manipulated these
devices exhibit elastic properties. Post processing steps include cutting the
device to fit the glass slide and creating fluid flow channels from the top
of the device to the microchannel. The final devices vary in height but are
approximately a centimeter tall. Then these devices were plasma-bonded
to glass slides with a diameter of 30 mm.
Figure 18: Microfluidic device fabrication. (a) PDMS mixture prior to
curing. (b) Cured PDMS on inverse molds. (c) Device prior to printing.
The microchannels prior to the internal sol-gel coating, shown in Figure
19a, have a pure PDMS border. After the sol-gel coating, the devices
exhibit a dark border along the edges of the microchannel, shown in Figure
19b. Finally, the fully fabricated devices, shown in figure 18c, are prepared
for printing.
44
Figure 19: Central chamber of the microfluidic device (a) before, and
(b) after sol-gel coating. The sol-gel coating is visible as a thin black
border on the walls of the chamber.
4.3 Proof of Concept Studies
Initial proof of concept testing involved fabrication of tubules from two
candidate materials, IP-L 780 and OrmoComp. IP-L 780 is a liquid pho-
toresist that has been used to produce the highest resolution prints on the
Nanoscribe to date [54]. However, it is autofluorescent, which may pose
challenges for fluorescent imaging or assay studies. OrmoComp is a glass-
like material with a high thermal and mechanical stability that has proven
to be non-cytotoxic in multiple studies [55, 56]. OrmoComp was initially
identified as the photoresist of choice for this project due to its material
properties and its biocompatibility. However, this material produced prints
with compromised structural integrity, a lack of agreement to the print file,
and inconsistency between print tests. Figure 20a shows the design for a
solid tubule that was printed with OrmoComp. The inconsistencies of print
results observed amongst identical print parameters are shown in Figure
20b and Figure 20c.
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Figure 20: Printing studies with OrmoComp. (a) CAD rendering of the
solid tubule design. The design features a rectangular base to ensure that
the tubule is supported on the glass slide. Previous prints without this
modification failed to attach. (b) Deformed OrmoComp tubule on a glass
slide. (c) Burned OrmoComp tubule on a glass slide.
In both cases, the structure was highly deformed and unrepresentative
of the designed tubule. In Figure 20c, this was due to burning of the
material. Burning was visible during multiple prints as dark “bubbles”
that emerged rapidly and compromised the laser’s ability to further cure
the photoresist. The print job was aborted after the observation of burning.
Despite multiple attempts to adjust the printing parameters and file
properties, OrmoComp could not be reproducibly or reliably printed, whether
due to structural deformation or burning. On the other hand, IP-L 780
structures could be consistently reproduced and demonstrated agreement
between the CAD file and print outcomes. Figure 21 shows the design and
print results of a fenestrated IP-L 780 tubule that was printed on a glass
slide. The design in Figure 21a features multiple sets of equally sized pores
that permeate the wall of the tubule.
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Figure 21: Printing studies with IP-L 780. (a) CAD rendering of the
fenestrated tubule design. (b) SEM image of the printed tubule on a glass
slide. (c) SEM image of pores.
The agreement of the print with the CAD file is evident upon inspection
of Figure 21b. The resolution of the print is further demonstrated by
the contour and hatching lines visible around the pores in Figure 21c. In
addition, the pores have a consistent size and spacing. Based upon these
results, IP-L 780 was selected as the printing material for the remainder of
the project.
4.4 Barrier Tests
A microfluidic device consisting of two parallel channels connected in
the center by a short intermediate channel was created for pressure testing
(Fig. 22a). This device is designed such that the central connecting chan-
nel can house a printed barrier that separates the parallel channels. The
purpose of this experiment was to apply fluid flow in the parallel channels
to confirm the integrity of the seal between the printed structure and the
walls of the device. The open central channel prior to printing is shown in
Figure 22a. A semicircle-shaped barrier according to the dimensions shown
in Figure 22c was printed inside the channels. The result of the print is
shown in Figure 22b.
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Figure 22: H-shaped microfluidic device showing (a) the sol-gel coating
prior to printing, and (b) the 3D printed barrier. (c) CAD rendering of
the semicircle-shaped 3D printed barrier.
Upon visual inspection, the barrier appears to be aligned in the center
and in contact with both sides of the channel. This observation was con-
firmed by applying fluid flow to one of the channels. Figure 23 shows the
initial application of the flow. The pressure was progressively increased,
at which point the seal was compromised and fluid flowed rapidly out of
the channel. No fluid flowed across the barrier prior to bursting, indicating
that there was a complete seal with the wall preventing leakage.
Figure 23: Results from the application of fluid to one of the parallel
channels. (a) Demonstrated integrity of the barrier under low pressure
conditions. (b) Bursting of the barrier as the pressure was increased. (c)
Outcome immediately after bursting. Fluid flowed rapidly out of the
channel.
4.5 Solid Tubules
For prints containing solid tubules, a cross-shaped microfluidic device
consisting of two perpendicular channels was created (Fig. 25). This design
enabled the tubules to be sealed to either end of the channels and printed
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across the center. The mold design featured a triangular channel structure
unlike that of the H-shaped microfluidic devices. A mold containing these
triangular channels was printed using IP-L 780, followed by application and
curing of PDMS and bonding to a glass slide. Holes were then punched
to create four outlets for flow at each end of the cross. The purpose of
this experiment was to show that a tubule with the desired dimensions
could be printed in a microfluidic device prior to investigating the fenes-
trated designs. After constructing the tubule in CAD (Fig. 24a), triangular
structures with a cylindrical opening the size of the tubule inner diameter
(block ends) were added to either end (Fig. 24b). These structures serve
as attachment points on either end of the triangular microfluidic channels.
Figure 24: (a) CAD rendering of the solid tubule. (b) CAD rendering of
the tubule with “block ends” for attachment to the microchannel walls.
(c) SEM image of a block end connected to a solid tubule.
The inside of the microfluidic device prior to printing is shown in Figure
25a, and the result of the print is shown in Figure 25b. The tubules are
printed such that they barely make contact with the bottom of the device.
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Figure 25: Cross-shaped microfluidic device showing (a) the sol gel
coating prior to printing, and (b) the 3D printed tubule.
The shape present on the right side of the channel is likely dust or de-
bris that entered the channel following the initial fabrication process, as
debris was most often observed following application of the sol gel coating.
However, the debris did not interfere with the print. The block ends of the
printed tubule appear to make contact with the walls of the channel, al-
though there is a slight gap on the right side. The channel has a segmented
appearance.
4.6 Unoptimized and Optimized Tubules
For prints containing fenestrated tubules, a microfluidic device consist-
ing of a square-shaped central chamber with four outlets was created. This
design enabled the tubules to be sealed to either end of the channels and
printed across the center. The open space in the chamber is representative
of the area that would be occupied by cells in an organ-on-a-chip device.
The mold design featured the same triangular channel structure as for the
solid tubule prints. A mold containing these channels was printed using IP-
L 780, followed by application and curing of PDMS and bonding to a glass
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slide. Holes were then punched to create four outlets for flow at each outlet.
After constructing the tubule in CAD (Fig. 26), triangular structures with
a cylindrical opening the size of the tubule inner diameter (block ends)
were added to either end. These structures serve as attachment points on
either end of the triangular microfluidic channels.
Figure 26: CAD rendering of the unoptimized tubule. (a) 510 µm long
tubule. (b) Zoomed in view of pores with radii of 0.75 µm. (c) Cross
section of the tubule with dimensions.
Fenestrated microchannels with a uniform pore radius of 0.75 µm were
successfully printed inside the microfluidic devices. The results from this
print of the unoptimized tubule are shown in Figure 27.
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Figure 27: Unoptimized tubule inside a microfluidic device. (a) Device
with sol gel coating prior to printing. (b) Device containing printed
unoptimized tubule. (c) Magnified image of the seal between one block
end of the unoptimized tubule and the microchannel walls.
Upon visual inspection, the unoptimized microchannel appeared to be
sealed within the microfluidic chamber. Debris was present inside the de-
vice but did not interfere with the microchannel fabrication process due
to its location away from the print. Distinct pores are displayed along the
length of the microchannel in Figure 27b, and a sealed barrier is shown in
Figure 27c.
Following the successful fabrication of an unoptimized microchannel, an
optimized microchannel was fabricated using the pore radii calculated in
Section 4.1.
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Figure 28: CAD rendering of the optimized tubule. (a) 510 µm long
tubule. (b) Zoomed in view of pores in the initial section. (c) Zoomed in
view of pores in the terminal section.
Fenestrated microchannels with gradually increasing pore radii were
successfully printed inside the microfluidic devices. The results from this
print of the optimized tubule are shown in Figure 29.
Figure 29: Optimized tubule inside a microfluidic device. (a) Device
containing printed optimized tubule. (b) Magnified image of the seal
between one block end of the optimized tubule and the microchannel
walls.
The optimized microchannel also appeared to be sealed within the mi-
crofluidic chamber. The device appeared to contain nearly no debris, and
pores are present along the length of the microchannel (Fig. 29b). Addi-
tional imaging was performed to examine the pore size distribution along
the length of the optimized microchannel.
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Figure 30: Zoomed in view of pores in (a) the initial segment of the
optimized microchannel, and (b) the terminal segment of the optimized
microchannel.
Upon visual inspection, the pore sizes at the terminal end of the opti-
mized microchannel appear to be larger in diameter (Fig. 30).
4.7 Fluid Flow Testing
Fluid containing 300 nm autofluorescent particles was run through an
optimized tubule to examine the flow distribution. This tubule was 260
µm long with 25 sets of pores (n=25).
Figure 31: Fluorescence micrographs of fluid testing experimental
results. (a) Tubule before application of fluid. Images taken (b) 1 second,
(c) 2 seconds, (d) 3 seconds, and (e) 7 seconds after initiating fluid flow.
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After inspection of fluid flow images, it was observed that fluid flow
remained at a constant flow rate throughout the length of the tubule (Fig.
31). Fluid distribution began to assume even outflow by 2 seconds (Fig.
31c-d), and maintained this evenly distributed outflow along the length of




According to results obtained in COMSOL, a fluid flow model was cre-
ated such that the output volumetric flow rates along the length of the
construct remained relatively constant. In comparison to a near 100% de-
crease in flow rate at the 50th pore in the unoptimized model, the optimized
model demonstrated a modest decrease of only around 18%. Despite this
improvement, the model is clearly not idealized. This is likely due to the
definition of the length between pore rows, which is considered from the
center of one set of pores to another. The equation used to calculate R2
based upon this length is governed by the assumption that this segment of
the tube is solid. However, due to the sets of pores on either side, there is
a smaller overall surface area than assumed by the equation. As the pores
become larger, this effect is more significant, resulting in greater deviations
from the expected flow rate. Because RT is marginally smaller than cal-
culated, the overall pressure in the central tube is lower than calculated,
eventually leading to a measurable difference in the flow rate out from the
pores.
The pores in this model were designed such that the spacing between
pore rows and the diameter of the pores in each row were constant. These
conditions facilitated the derivation of the general form equation and the
creation of a model that maintains a consistent output volumetric flow
rate. However, fenestrae in vivo are arranged randomly along the length of
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the sinusoid and have variable diameters on the order of nanometers. Due
to the complexity of creating a mathematical model for these randomly
varying parameters, the effect of constant vs. random pore size (within
the pore rows) and constant vs. random spacing between pore rows was
not investigated. However, it may be useful to investigate the impact of
this random arrangement on cell viability and metabolic activity in future
models that do not rely on this constraint.
Within the scope of this project, the introduction of variable pore sizes
into the model was an important consideration for maintenance of a con-
stant output volumetric flow rate. This is because the initial goal was
to culture one cell population only, primary hepatocytes, in the area sur-
rounding the tubule. However, sinusoids in vivo also contain endothelial
cells that compose the walls of the vessels, where the fenestrae are formed
via junctions between neighboring cells. As a result, these endothelial cells
play a central role in the regulation of fluid flow and nutrient exchange
between the sinusoid and the surrounding environment. A more biolog-
ically complex model that contains endothelial cells would necessitate a
fundamentally different tubule architecture in which the fenestrae them-
selves can be formed by the cells. Therefore, a tubule design for this model
would have to provide a sinusoid-shaped structure for cell adhesion while
maintaining sufficient open space for nutrient exchange to be unobstructed
by the printed wall. Assuming the cells can assemble into a monolayer in
such a model, they should be capable of replicating their in vivo functions
by altering vascular tone in response to shear stresses under varying flow
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conditions. Therefore, incorporation of pores into the 3D printed tubule
would not be necessary.
5.2 Fabrication Results
Figures 20b and 20c show the two types of deformed structures that
were printed using the initial material, OrmoComp. Despite many at-
tempts, a tubule in agreement with the CAD design could not be printed
due to increased resulting inconsistency as compared to alternative mate-
rials. Therefore, IP-L 780 was chosen as the material for this project.
The initial molds for the microfluidic channels were created with a
semicircle shape, and this was the structure that was used to create the
H-shaped molds. However, during the project it came to light that a trian-
gular shaped microfluidic channel was beneficial for obtaining a complete
seal with the walls of the channel [7]. Generally, it was discovered that out-
ward tapering structures improved sealing performance of the 3D printed
structures. It is hypothesized that this is due to a phenomenon called
“shadowing” in which focusing deviations occur due to the path of the
laser through certain portions of the PDMS. This prevents photocuring of
some of the material in the channel, resulting in an incomplete seal. The
triangular mold design used to overcome this limitation is shown in Figures
32 and 33.
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Figure 32: CAD rendering of the mold used to fabricate microfluidic
devices with triangular channels. The width of the central chamber is 250
µm.
Figure 33: 3D printed mold with triangular channels. (a) SEM image of
the central chamber. (b) SEM image of the triangular channel connected
to the central chamber. (c) SEM image of the mold coated with PDMS.
For the initial solid tube prints, a cross shaped mold was used (Fig.
25a). For the fenestrated prints, a mold with narrower channels and an
open inner chamber was created to model the space where cells would be
cultured around the tubule (Fig. 27a).
The purpose of the tests conducted using the H-shaped mold was twofold.
The first goal was to confirm that an IP-L 780 structure could be printed
inside a tubule such that it was completely sealed to the outside walls of the
channel. The fluid flow experiment demonstrated that when water flowed
along one side of the channel, no liquid was visible on the other side. There-
fore, no leakage occurred through the barrier, confirming the integrity of
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the seal. When the pressure was increased, the structure eventually burst
and the fluid on the right side was pushed out of the channel. However, it is
unclear whether the seal with the wall or the structure itself was compro-
mised. A future modification of this experiment could involve gradually
increasing the pressure using the Fluigent and recording the pressure at
which bursting occurs for both a semicircle-shaped barrier in semicircular
channels and a triangle-shaped barrier in triangular channels.
5.3 Printing Results
The first prints were conducted with a solid tubule design to confirm
that tubes could be printed inside the microchannels. In Figure 25a, which
shows the channels of the microfluidic device following sol gel, there are
some visible particles along the vertical direction in addition to a large
piece of debris on the right side of the horizontal channel. Debris was most
likely introduced during the sol gel process, by which solutions and air are
pushed through the channels. Reusing tubing that was not clean or failing
to push the air through at a high enough speed could introduce debris
into the channels or fail to clear it out. This problem was mitigated by
using new tubing and catheter couplers each time for sol gel. As seen in
Figure 25b, the debris did not appear to interfere with the printing process.
While the barrier on the left appears to make full contact with the walls
of the channel, there is a slight gap on the bottom portion of the barrier
at the right. This is likely due to a slight error when orienting the initial
location for the print. In future prints this problem was able to be avoided.
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The segmented appearance of the channel is due to restrictions on the
Nanoscribe print area as a result of the working distance of the print laser,
which is around 350 µm. With the addition of the glass print substrate,
the maximum print length that can be achieved without moving the print
substrate is about 250 µm. As a result, the printer must move the stage to
print constructs that are longer than approximately 250 µm. The visible
segments in the channel show the starting point of the print after moving
the stage.
5.4 Experimental Verification of Designed Fenestrae
Fluid flow testing yielded results showing near uniform fluid flow rates
throughout the length of the tubule. While the tubule was burned dur-
ing the printing process, it appears that the burns were minor and had no
effect on fluid flow through the fenestrae of the tubule. Furthermore, it
can be seen that fluid flow through the tubule remained uniform even in
the presence of debris. Experimental fluid flow observations of the opti-
mized tubule correlate with theoretical calculated results of equal output
volumetric flow rates generated in COMSOL. Thus, the engineered micro-
tubule with fenestrae yields near-uniform flow rates along the length of the
tube which correlates both theoretical and experimental work.
A tubule with a length of 260 µm was used for fluid testing as opposed
to the 510 µm long tubule investigated in the theoretical studies. This is
because the Nanoscribe must move the stage to print the longer tubule,
resulting in visible creases where the tubule is stitched together. Initial
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fluid flow testing showed that tubules burst at the location of stitching
(data not shown). Therefore, only tubules that meet the constraints of the
Nanoscribe print area can feasibly be utilized for fluid flow. For the fluid
flow testing, a construct with a total length of 290 µm including the block
ends was successfully printed without moving the stage.
5.5 Future Work
Figure 34: CAD representation of a cell-seeded chamber with a central
fenestrated tubule for diffusion of vital nutrients.
Following successful fluid flow through the optimized tubule, the device
would be able to evenly distribute media to surrounding cultured cells to
resemble the physiological conditions of the liver (Fig. 34). The effects
of the device could be ascertained by culturing hepatocytes in the open
chamber and observing the cell viability and metabolic function. A hep-
atic cell line that could be used is Huh-7.5. Huh-7.5 cells produce albumin
and have the same drug metabolism as primary hepatocytes, along with
being permissive to hepatitis C infection. They are widely used because of
their ease of growth and cultured in a media with Dimethyl Sulfoxide [57].
Cell viability could be observed using a live/dead assay. These kits deter-
62
mine the cell viability through the cell staining method, which marks living
cells with green fluorescent dyes and dead cells red fluorescent dyes [58].
To further resemble the environment of the human liver, endothelial cells
could be seeded in the interior of the microchannels. This would mimic
the endothelial cells that compose the fenestrated liver sinusoid. Albumin,
an essential protein made in the liver, is vital in maintaining oncotic pres-
sure and transporting hormones and various drugs. Measuring the presence
and relative amounts of albumin is one of the standard liver function tests.
The metabolic activity of the hepatocytes could further be evaluated by
observing albumin production through an enzyme-linked immunosorbent
assay (ELISA) [59, 60]. Cytochrome P450 enzymes are also responsible
for metabolizing drugs, and thereby their levels are indicative of hepatic
metabolic function. These can be analyzed through quantification of im-
munofluorescence microscopy through ImageJ using anti-CYP450 primary
antibodies (Abcam) and a secondary fluorescent antibody [61].
Another future direction involves the incorporation of multiple 3D printed
tubules into a single microfluidic chamber. Liver sinusoids in vivo have a
spacing of about x µm, which enables adequate dispersion of nutrients to
all surrounding hepatocytes. In order to replicate this architecture and
prevent cell death due to inadequate proximity to the sinusoid, multiple
tubules could be printed in a larger chamber with a spacing of about x µm.
The inner diameter of the tubule is 35 µm, thus, given that liver endothelial
cells are 6.5 µm in diameter [52], it is anticipated that fluid flow will pass
through the tubule of the device. Furthermore, we would anticipate that a
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gradient away from the tubule would exist for fluid and thus nutrient flow
should cells be seeded in this device.
This device that resembles the physiological environment of the human
liver would have many further applications. It could be used in the early
stages of drug testing to provide more accurate predictions of the interac-
tions between the drug and cells than traditional 2D cell culture methods.
For initial testing, one relevant drug that could be tested is acetaminophen,
which is known to be a cause of liver damage and failure in certain doses.
The model can also be applied to study the effects of alcohol on the liver.
As the body is exposed to alcohol, the liver produces a number of toxic
substances including acetaldehydes and highly reactive molecules called
free radicals. These can induce further liver damage and disease [62]. By
exposing the liver cells in our model to alcohol, this process could be ob-
served and analyzed more effectively than previous traditional methods of
cell cultures in petri dishes. Through these experiments, our model could
be utilized for further research on the liver and liver diseases.
Our liver model could also be used to study viral-host interactions and
other interactions with the liver in a more physiologically accurate manner.
If our model induces greater cell differentiation, it is possible that our
liver on a chip device may result in better hepatocyte expression of liver
specific factors, which could enable greater permissability of infectivity and
longevity of primary hepatocytes if cultured in our model. This could be
of use in culturing hepatitis B virus, which requires liver specific factors
for replication such as sodium taurocholate transporting peptide (NTCP)
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receptors [63]. The ability to improve cell differentiation when compared to
monolayer cell cultures could prove to be useful, as differentiation of cells
in culture systems has been shown to be important with viruses such as
human papillomavirus. [64, 65]
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6 Conclusion
The fabrication of physiologically relevant organ-on-a-chip models is an
apparent, essential next step towards improving drug research and disease
modeling in a sustainable manner. Increasing the drug research success rate
through more accurate modeling of the internal functions of the body in the
pharmaceutical industry will lead to a faster, cheaper, and more effective
drug development process. This microfluidic model provides physiologi-
cal resemblance to the human liver in comparison to traditional cell cul-
ture devices, adding to the knowledge of currently existing organ-on-a-chip
technology. With optimized tubules that are able to allow for even distri-
bution of media to the cells, this model better resemble the liver sinusoids
that allow the nutrients from the blood to evenly reach the surrounding
cells. This device therefore leads researchers one step closer to being able
to conduct drug testing using an organ-on-a-chip model of the liver that
will replicate in-vivo cell functions.
This liver model, once successfully tested for cell viability and metabolic
activity, could be used in conjunction with other organ-on-a-chip models
to test the overall effects of drugs within a system in the body. For exam-
ple, our proposed liver on a chip model could be combined with existing
microfluidic modeling systems, such as the kidney on a chip model, in or-
der to study the effect of a drug on the entire excretory system. It could
furthermore be integrated to create body on a chip devices [66, 67, 68, 69].
Additionally, this research model could help eliminate the need for animal
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testing by providing a more accurate alternative for human systems. The
advancement of therapeutics is impeded by rudimentary drug testing mod-







Qp = 7.7798*10ˆ-16; %Set the flow rate through the pores ...
(mˆ3/s)
%--Define Tube Dimensions Here to Quantify Rt----
L = 10; %Length between pores (um)
Rtube = 17.5; %Inner Radius of the tube (um)
viscosity = 0.6922*10ˆ-3; %Viscosity of water at 37 deg C ...
(Pa*s)
Rt = (8*viscosity*(L*10ˆ-6))/(pi*((Rtube*10ˆ-6)ˆ4)); ...
%(N/mˆ2)/(mˆ3/s)
%--Define Tube Dimensions Here to Quantify R1----
Lp = 5; %Thickness of tube wall (um)
Rpore = 0.75; %Radius of the first pore (um)
viscosity = 0.6922*10ˆ-3; %Viscosity of water at 37 deg C ...
(Pa*s)
Npore Parallel = 5; %Number of pores at each pore row
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Rpore1 = (8*viscosity*(Lp*10ˆ-6))/(pi*((Rpore*10ˆ-6)ˆ4)); ...
%(N/mˆ2)/(mˆ3/s)
R1 = Rpore1/Npore Parallel; %(N/mˆ2)/(mˆ3/s)
Nmax = 50; %Set Total Number of Pore Rows (Sets of resistors)
R = zeros(1,Nmax);
R(1) = R1; %Set R1
for n = 2:Nmax
x = ...
((Nmax+1-n)*R(n-1)-(((Nmax+2-n)*(Nmax+1-n))/2)*Rt)/(Nmax+2-n); ...
%Resistance of pore set
R(n) = x;
end
Rind = R*Npore Parallel; %Equation for resistance of each ...
individual pore
indradius = ((8*viscosity*(Lp*10ˆ-6))./(Rind*pi)).ˆ(1/4); ...
%Equation for radius of each individual pore
Qref = Nmax+1;
Q(Qref) = (R(Nmax)/Rt)*Qp; %Flow rate out of central tubule






Q(q) = y; %Flow rate through central tubule at each ...
pore row
end
RTot(Nmax) = Rt+(Rt*R(Nmax))/(Rt+R(Nmax)); %Total ...
equivalent resistance of tubule
RTot Ref = Nmax-1;




RTot(Tot) = z; %Total equivalent resistance at each ...
pore row
end
rowresistance = R %Outputs the total resistance at each ...
pore row (N/mˆ2)/(mˆ3/s)
poreresistance = Rind %Outputs the resistance of the ...
individual pores at each pore row (N/mˆ2)/(mˆ3/s)
flowrate = Q %Outputs the flow rate in the intermediate ...
tube section at each pore row (mˆ3/s)
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totalresistance = RTot %Outputs the total equivalent ...
resistance at each pore row (N/mˆ2)/(mˆ3/s)
dp = Q(1)*RTot(1) %Pressure differential (inlet-outlet) of ...
central tube (N/mˆ2)
radii = indradius %Radius of the individual pores at each ...
pore row (m)
Q1 = Q(1) %Input flow rate into central tubule (mˆ3/s)
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8 Glossary
Albumin - A globular protein that is produced by the liver that is
integral to maintaining oncotic pressure and the transportation of drugs
and hormones.
Black Box Warning - Warning placed by the FDA indicating that
there are serious risks associated with the drug.
Central vein - Receives blood that has been filtered through the lobule
and returns it to the heart for recirculation.
Computer-Aided Design - The use of computer software to virtually
design and create object models.
Cyclic olefin copolymer - A clear amorphous polymer with a low
moisture absorption rate and is very resistance to acids and bases.
Enzyme-Linked Immunosorbent Assay (ELISA) - A biochemical
assay which can detect an antigen in a sample.
Extrusion Based Printing - Depositing of material point by point
through a nozzle.
Fenestrated endothelium - A layer of endothelial cells containing
small pores that allow for the exchange of molecules between blood in the
sinusoids and the hepatic cords.
High Throughput Screening - An assay method to test many reac-
tions systematically and efficiently.
Hepatocytes - Cells of the main parenchymal tissue of the liver that
are involved in the liver’s most important functions. Make up 70-85% of
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the liver’s mass.
Hepatic cord - A mass of hepatocytes arranged in a radiating fashion
outward from the central vein of the liver lobule.
Hypoxic - A condition in which the tissues are deprived of adequate
oxygen supply.
In vitro - Performing a test using living cells outside of the organism.
In vivo - A test performed inside of a living organism.
Laser Lithography - A type of stereolithography that uses short laser
pulses to polymerize photosensitive material, revealing only the desired 3D
structure.
Live Dead Assay - A chemical test used to quantify cell life through
staining living cells one color and dead cells another.
Lobule - A small, repeating subunit of the liver composed of hepato-
cytes that filters incoming blood.
Microfluidic Device - A cell culture device with a set of microchannels
etched in that allows for control of the fluid flowing through the channels.
Nanoscribe - A 3D printer that uses laser lithography techniques to
print in dimensions as small as nanoscale.
Organ-on-a-Chip - A 3D microfluidic cell culture chip that can rep-
resent the functions and physiological responses of an organ.
OrmoComp - A biocompatible gel with high chemical and thermal
stability.
Paracrine Signaling - A form of cell communication where one cell
produces a signal to alter the behavior or differentiation of nearby cells.
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Photocurable resin - A substance that is hardened when exposed to
ultraviolet light.
Photolithography - Microfabrication process to transfer intricate ge-
ometries on a mask to a silicon wafer.
Photopolymer - A polymer that changes properties when exposed to
light.
Photoresist - Substrate that is chemically cured through contact with
UV light.
Photomask - An opaque substrate with patterned transparencies, de-
signed to allow UV light shine through in a defined way.
Piezo-actuators - Converts electrical energy into mechanical energy
to allow for precise movement, with submicron scale accuracy, in positional
based systems.
Polycarbonate - Plastic used to create strong tough materials that
are often clear.
Polydimethylsiloxane - Biocompatible silicon substrate.
Polyjet Printing - Dispenses microdroplets of photopolymers to create
a 3D object.
Portal vein - Blood vessel that carries nutrient-rich blood from the
gastrointestinal tract and spleen to the liver.
Sinusoids - Small blood vessels that permeate the liver lobule to allow
blood flow throughout the liver.
Stereolithography - 3D printing technique that uses focused light to
cure liquid polymers and create 3D structures.
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